We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Government response to the ACMD's advice on the prescribing of controlled drugs by paramedics and on the administration rights of morphine by injection for therapeutic radiographers.
First published during the 2022 Truss Conservative government
The chair of the Advisory Council on the Misuse of Drugs (ACMD) writes to Lynne Featherstone about the Misuse of Drugs (Designation) Order 2001.
Letter to the chair of the ACMD inviting them to establish a working group to respond to the recent white paper on drug possession.
Lynne Featherstone writes to the ACMD chair regarding synthetic cannabinoids.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Secretary in response to the 6 January letter on GHB and GBL.
Letter to the Home Office setting out the ACMD’s interim advice in relation to diversion and illicit supply of medicines.
Report finds prescription-only medicines are being used to supplement the use of other illicit drugs, including cocaine and heroin.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Secretary advising on COVID-19 emergency measures to enable the supply of controlled drugs.
The letter is a request for evidence for the ACMD’s “community-custody transitions” working group.
The chair of the Advisory Council on the Misuse of Drugs (ACMD) writes to Theresa May about government priorities.
The chair of the ACMD responds to the Home Secretary's letter about the Psychoactive Substances Bill.
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of Cumyl-PeGaClone.
The chair of the ACMD responds to the Home Secretary's invitation on 29 November to become a member of the drug strategy board.
A report published today (Monday, 12 December) by the Advisory Council on the Misuse of Drugs investigates the causes of the increase and potential responses.
ACMD report on definitions of scope for the Psychoactive Substances Bill.
The chair of the Advisory Council on the Misuse of Drugs writes to Karen Bradley about Pregabalin and Gabapentin.
Letter commissioning the Advisory Council on the Misuse of Drugs (ACMD) to work on a project to prevent drug use in children and young people.
First published during the 2022 to 2024 Sunak Conservative government
The second and concluding report on opioid substitution therapy from the Advisory Council on the Misuse of Drugs (ACMD).
A review of the evidence of use and harms of novel benzodiazepines.
First published during the 2019 to 2022 Johnson Conservative government
The (ACMD) Recovery Committee’s publishes briefing paper on the prevention of drug and alcohol dependence.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).